- Asked by: Nicola Sturgeon, MSP for Glasgow, Scottish National Party
-
Date lodged: Wednesday, 03 October 2001
-
Current Status:
Answered by Susan Deacon on 6 November 2001
To ask the Scottish Executive whether it will include a specific nursing voice on the new unified NHS boards in line with the provision of the Munich Declaration on nurses and midwives which urges that relevant authorities ensure that there is a nursing and midwifery contribution to the decision-making process at all levels of policy development and implementation.
Answer
Our policy is to ensure that all staff have the opportunity to contribute appropriately to the decision-making process in NHSScotland, without favouring one profession over another. Specifically, all 15 new NHS Boards include - as a full member - the Staff Side Chair of the Area Partnership Forum, to further reinforce the importance of partnership working. Additionally, each NHS Board is creating an Area Clinical Forum, which will bring together the chairs of all the local professional advisory committees, including the Nursing & Midwifery Committee. The Chair of the forum has a full seat on the NHS Board. Responsibility and accountability for direct patient care is still led at NHS Trust level. The trust board has been replaced by a trust management team, which must - by law - include a registered nurse or midwife as an Executive Director. On a national level, we plan to strengthen the role of nurses and midwives in policy development by establishing a new Nursing and Midwifery Forum, details of which will be discussed with the main professional, academic and staff representative bodies.
- Asked by: Nicola Sturgeon, MSP for Glasgow, Scottish National Party
-
Date lodged: Tuesday, 02 October 2001
-
Current Status:
Answered by Susan Deacon on 23 October 2001
To ask the Scottish Executive whether single drug sedation only may be used in general dental practice and, if so, whether such use is in accordance with the proposals outlined in the Scottish Intercollegiate Guidelines Network (SIGN) draft guideline on the safe sedation of children.
Answer
Yes. Since 13 August 2001 only single drug use is allowed for sedation in general dental practice in Scotland. This is in line with the SIGN document, but as this document is only in a draft format, any direct comparisons are currently inappropriate.
- Asked by: Nicola Sturgeon, MSP for Glasgow, Scottish National Party
-
Date lodged: Wednesday, 03 October 2001
-
Current Status:
Answered by Susan Deacon on 23 October 2001
To ask the Scottish Executive what action it is taking in partnership with South Glasgow University Hospitals NHS Trust to reduce waiting times for hip replacement operations in the Trust's area.
Answer
The Scottish Executive set out in Our National Health: A plan for action, a plan for change our commitment to work with NHSScotland to reduce waiting through increased investment and improved working practices. Reductions in waiting times are a priority for the new NHS boards. I understand that NHS Greater Glasgow is currently working to develop and improve orthopaedic services across its area.
- Asked by: Nicola Sturgeon, MSP for Glasgow, Scottish National Party
-
Date lodged: Tuesday, 25 September 2001
-
Current Status:
Answered by Susan Deacon on 9 October 2001
To ask the Scottish Executive how many nurses currently employed by the NHS also undertake work for nursing agencies.
Answer
The information is not held centrally. Individual NHS Trusts may, however, have this data as part of the information they need to comply with the Working Time Regulations.
- Asked by: Nicola Sturgeon, MSP for Glasgow, Scottish National Party
-
Date lodged: Thursday, 30 August 2001
-
Current Status:
Answered by Susan Deacon on 27 September 2001
To ask the Scottish Executive whether it intends to publish comprehensive NHS waiting list figures on a quarterly basis.
Answer
Information and Statistics Division of the Common Services Agency will continue to publish waiting list data as at present.
- Asked by: Nicola Sturgeon, MSP for Glasgow, Scottish National Party
-
Date lodged: Thursday, 23 August 2001
-
Current Status:
Answered by Susan Deacon on 20 September 2001
To ask the Scottish Executive how the potential appearance of treatment-acquired disease among haemophiliacs is monitored, given the experience gained from the appearance of hepatitis C as a treatment-acquired disease among haemophiliacs.
Answer
I refer the member to the answer given to question S1W-17745.
- Asked by: Nicola Sturgeon, MSP for Glasgow, Scottish National Party
-
Date lodged: Thursday, 23 August 2001
-
Current Status:
Answered by Susan Deacon on 20 September 2001
To ask the Scottish Executive what proportion of haemophiliacs currently have a treatment-acquired illness or disability.
Answer
I refer the member to the answer given to question S1W-17745.
- Asked by: Nicola Sturgeon, MSP for Glasgow, Scottish National Party
-
Date lodged: Thursday, 23 August 2001
-
Current Status:
Answered by Susan Deacon on 20 September 2001
To ask the Scottish Executive how many haemophiliacs have died of treatment-acquired illnesses in each of the last 10 years for which records are available.
Answer
I refer the member to the answer given to question S1W-17745.
- Asked by: Nicola Sturgeon, MSP for Glasgow, Scottish National Party
-
Date lodged: Thursday, 23 August 2001
-
Current Status:
Answered by Susan Deacon on 20 September 2001
To ask the Scottish Executive how many haemophiliacs have died in each of the last 10 years for which records are available.
Answer
This information is not held centrally. I have written to you separately giving contact details to allow you to obtain the information requested in this and your other questions (S1W-17746, S1W-17747 and S1W-17748) through the Scottish Haemophilia Directors.
- Asked by: Nicola Sturgeon, MSP for Glasgow, Scottish National Party
-
Date lodged: Wednesday, 05 September 2001
-
Current Status:
Answered by Susan Deacon on 19 September 2001
To ask the Scottish Executive whether batches of blood and blood products produced before heat treatment was introduced in 1987 continued to be used to treat patients in the NHS after heat treated blood products were available and, if so, when they ceased being used.
Answer
Factor VIII concentrates issued by SNBTS since December 1984 have been heat-treated. Initially this heat treatment was to 68ºC but SNBTS subsequently developed a new product able to withstand a more severe heat treatment to 80ºC.This new product first became available for routine use in late April 1987 but in order to establish patient tolerability it was phased into use carefully over a number of weeks. I understand that all haemophilia A patients in Scotland who were being treated with SNBTS Factor VIII were receiving the new product by early August 1987, by which time any residual use of the SNBTS 68ºC treated product had ceased.
